BMEA — Biomea Fusion Share News
0.000.00%
Last trade - 00:00Biomea Fusion Inc expected to post a loss of 61 cents a share - Earnings Preview
Brief: Biomea Fusion, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Biomea Fusion Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: Biomea Fusion Q4 Basic EPS USD -0.81
Biomea Fusion Inc expected to post a loss of 92 cents a share - Earnings Preview
Brief: Biomea Fusion Says Mick Hitchcock Named Interim CEO Replacing Thomas Butler
Brief: Biomea Fusion Says Franco Valle Resigns As CFO
Brief: Biomea Fusion Announces Positive Topline Results From Ongoing Phase II COVALENT-111 Study
Brief: Biomea Fusion Announces Preliminary Data From Ongoing Covalent-103 Study Of Investigational Covalent Flt3 Inhibitor Bmf-500 In Relapsed Or Refractory Acute Leukemia
Brief: Biomea Fusion Announces Approval Of “Icovamenib” As International Nonproprietary Name For Bmf-219
Biomea gains as FDA lifts clinical hold on diabetes trials
US FDA lifts clinical hold on Biomea's diabetes trials (updated)
US FDA lifts clinical hold on Biomea's diabetes trials
U.S. RESEARCH ROUNDUP-CH Robinson Worldwide, Lam Research, Meta
U.S. STOCKS ON THE MOVE-Affirm, Calavo Growers, Shoals Technologies
U.S. STOCKS ON THE MOVE-Spotify, Affirm, Calavo Growers
U.S. STOCKS ON THE MOVE-Sage, General Motors, Viridian
U.S. STOCKS ON THE MOVE-Eli Lilly, Rocket Lab, Yext
Biomea Fusion falls as Truist cuts to "hold"